Advanced Enzyme
Ticker >

Advanced Enzyme share price

Advanced Enzyme Technologies Ltd.

NSE: ADVENZYMES BSE: 540025 SECTOR: Pharmaceuticals & Drugs  72k   427   70

368.00
+8.50 (2.36%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 368.7

Today's Low

₹ 350.4

52 Week High

₹ 425.1

52 Week Low

₹ 252.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 4115.13 Cr.

Enterprise Value

₹ 4090.41 Cr.

No. of Shares

11.18 Cr.

P/E

33.6

P/B

7.16

Face Value

₹ 2

Div. Yield

1.36 %

Book Value (TTM)

₹  51.42

CASH

₹ 24.72 Cr.

DEBT

₹ 0.01 Cr.

Promoter Holding

43.49 %

EPS (TTM)

₹  10.95

Sales Growth

14.2%

ROE

11.05 %

ROCE

14.83%

Profit Growth

1.86 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

These are the brands of Advanced Enzyme Technologies Ltd.

evoxx DigeGrain DigePhos SEBrew SEBMash SEBake SEBStar SEBYeast Extractase Addclean

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year14.2%
3 Year7.99%
5 Year8%

Profit Growth

1 Year1.86%
3 Year-1.42%
5 Year9.12%

ROE%

1 Year11.05%
3 Year13.59%
5 Year13.89%

ROCE %

1 Year14.83%
3 Year18.26%
5 Year18.22%

Debt/Equity

0

Price to Cash Flow

81.82

Interest Cover Ratio

226.084848484848

CFO/PAT (5 Yr. Avg.)

0.922472733637448

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 43.49 0
Dec 2023 43.62 0
Sep 2023 45.92 0
Jun 2023 46.52 0
Mar 2023 49.87 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 0.168 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 226.084848484848.
  • The Company has been maintaining an effective average operating margins of 28.1147767314555% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 5.12596888720256.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.07171788432241.

 Limitations

  • The company has shown a poor profit growth of -1.41645448240504% for the Past 3 years.
  • The company has shown a poor revenue growth of 7.99231401142182% for the Past 3 years.
  • The company is trading at a high PE of 33.6.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 79.68 82.56 85.35 96.58 91.14
Total Expenditure 58.49 59.28 60.57 69.96 66.59
Operating Profit 21.19 23.28 24.78 26.62 24.55
Other Income 3.75 2.81 51.25 0.79 3.57
Interest 0.02 0.06 0.04 0.03 0.04
Depreciation 2.61 2.76 2.51 2.61 2.72
Exceptional Items 0 0 0 0 0
Profit Before Tax 22.31 23.28 73.48 24.76 25.36
Tax 5.68 5.78 6 6.38 6.24
Profit After Tax 16.64 17.5 67.49 18.38 19.12
Adjusted EPS (Rs) 1.49 1.56 6.04 1.64 1.71

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 222.09 247.35 283.47 272.8 311.53
Total Expenditure 169.21 170.4 182.62 199.97 236.45
Operating Profit 52.88 76.96 100.85 72.83 75.08
Other Income 5.61 9 6.82 9.08 9.81
Interest 2.72 1.29 0.24 0.27 0.33
Depreciation 8.56 8.81 9.01 9.56 10.28
Exceptional Items 0 0 0 0 0
Profit Before Tax 47.2 75.85 98.43 72.07 74.28
Tax 11.97 17.9 27.42 17.56 18.75
Net Profit 35.23 57.96 71.01 54.51 55.53
Adjusted EPS (Rs.) 3.16 5.19 6.36 4.88 4.97

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 22.33 22.34 22.35 22.36 22.37
Total Reserves 297.14 348.15 413.1 457.99 502.97
Borrowings 1.7 0.76 0.18 0 0
Other N/C liabilities 4.37 10.33 12.94 12.96 13.57
Current liabilities 44.98 35.63 41.04 36.31 36.9
Total Liabilities 375.89 422.68 489.6 529.62 575.8
Assets
Net Block 97.35 126.95 132.22 132.03 142.86
Capital WIP 1.26 4.58 1.96 3.25 5.61
Intangible WIP 5.74 5.38 5.38 5.44 5.42
Investments 120.46 119.85 151.56 172.68 185.48
Loans & Advances 38.8 34.04 35.14 35.76 38.36
Other N/C Assets 10.1 6.52 3.12 3.79 8.94
Current Assets 102.18 125.36 160.23 176.69 189.14
Total Assets 375.89 422.68 489.6 529.62 575.8
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 47.2 75.85 98.43 72.07 74.28
Adjustment 6.71 3.21 3.56 1.68 5.07
Changes in Assets & Liabilities -6.17 -20.38 9.07 -15.21 -12.6
Tax Paid -12.37 -12.7 -26.83 -21.44 -16.46
Operating Cash Flow 35.37 45.98 84.23 37.1 50.3
Investing Cash Flow -1.91 -24.94 -69.91 -14.24 -42.35
Financing Cash Flow -33.47 -18.56 -15.49 -10.87 -11.99
Net Cash Flow 0 2.48 -1.16 11.99 -4.05

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 49.87 46.52 45.92 43.62 43.49
advanced vital enzymes pv... 6.47 3.46 2.86 0.56 0.44
chandrakumar laxminarayan... 0.04 0.04 0.04 0.04 0.04
kishor laxminarayan rathi... 1.31 1.31 1.31 1.31 1.31
madhusudan kabra 0.64 0.64 0.64 0.64 0.64
prabhavati vasant rathi 0.82 0.82 0.82 0.82 0.82
rachana vasant rathi 2.36 2.36 2.36 2.36 2.36
rasika vasant rathi 2.36 2.38 2.38 2.38 2.38
reshma namita rathi 2.37 2.37 2.37 2.37 2.37
vasant rathi 32.64 33.14 33.14 33.14 33.14
abhijit kishor rathi 0.07 - - - -
amit kishor rathi 0.07 - - - -
anisha sunil attal 0.01 - - - -
ankit kishor rathi 0.09 - - - -
atharva green ecotech llp... 0.56 - - - -
jayesh madhusudan soni 0.01 - - - -
megha jhawar 0.01 - - - -
nikita madhusudan soni 0.01 - - - -
sanju madhusudan soni 0.01 - - - -
sunita sunil attal 0.01 - - - -
tejasvi madhusudan soni 0.01 - - - -
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 50.13 53.48 54.08 56.38 56.51
clarus capital i - - - - 1.28
hdfc small cap fund 4.26 4.26 3.47 3.61 3.67
icici prudential esg fund... - 2.79 2.34 1.77 1.77
investor education and pr... - - 0.11 0.11 0.11
llp 0.06 0.07 0.09 0.22 0.24
mukund madhusudan kabra 1.63 1.63 1.63 1.63 1.63
nalanda india equity fund... 8.91 8.91 8.91 8.91 8.91
orbimed asia iii mauritiu... 2.20 2.20 2.20 2.20 2.20
orbimed asia iii mauritiu... 9.88 9.88 9.88 9.88 9.88
pradip bhailal shah 1.85 1.85 1.83 1.81 1.81
sri sri ravi shankar trus... 1.05 1.05 1.05 1.05 -
investor education and pr... 0.11 0.11 - - -

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Advanced Enzyme Technologies informs about earnings call transcript21 Feb 2024, 2:56PM Advanced Enzyme Technologies informs about disclosure 20 Feb 2024, 10:41AM Advanced Enzyme Technologies gets nod to acquire additional stake of 5.89% in JC Biotech10 Feb 2024, 4:16PM Advanced Enzyme - Quaterly Results10 Feb 2024, 12:41PM Advanced Enzyme - Quaterly Results10 Feb 2024, 12:41PM Advanced Enzyme - Quaterly Results10 Feb 2024, 12:41PM Advanced Enzyme Technologies submits analyst meet intimation3 Jan 2024, 2:47PM Advanced Enzyme Technologies informs about disclosures18 Dec 2023, 5:08PM Advanced Enzyme Technologies informs about disclosure15 Dec 2023, 2:51PM Advanced Enzyme Technologies informs about disclosures7 Dec 2023, 5:03PM Advanced Enzyme Technologies informs about disclosures30 Nov 2023, 4:31PM Advanced Enzyme Technologies informs about disclosures20 Nov 2023, 4:48PM Advanced Enzyme Technologies informs about transcript of conference call17 Nov 2023, 5:03PM Advanced Enzyme Technologies informs about disclosure17 Nov 2023, 2:35PM Advanced Enzyme Technologies informs about disclosures 15 Nov 2023, 5:10PM Advanced Enzyme - Quaterly Results7 Nov 2023, 12:25PM Advanced Enzyme - Quaterly Results7 Nov 2023, 12:25PM Advanced Enzyme - Quaterly Results7 Nov 2023, 12:25PM Advanced Enzyme Technologies informs about analyst meet1 Nov 2023, 4:46PM Advanced Enzyme Technologies informs about disclosure 27 Sep 2023, 2:32PM Advanced Enzyme Technologies informs about disclosures13 Sep 2023, 4:51PM Advanced Enzyme Technologies informs about disclosure7 Sep 2023, 10:31AM Advanced Enzyme Technologies informs about transcript of conference call23 Aug 2023, 10:41AM Advanced Enzyme Technologies informs about disclosure18 Aug 2023, 1:09PM Advanced Enzyme Technologies informs about investor meeting17 Aug 2023, 5:04PM Advanced Enzyme - Quaterly Results12 Aug 2023, 11:12AM Advanced Enzyme - Quaterly Results12 Aug 2023, 11:12AM Advanced Enzyme - Quaterly Results12 Aug 2023, 11:12AM Advanced Enzyme Technologies informs about disclosure24 Jun 2023, 11:44AM Advanced Enzyme Technologies informs about disclosure 23 Jun 2023, 2:03PM Advanced Enzyme Technologies informs about disclosure20 Jun 2023, 1:40PM Advanced Enzyme Technologies informs about disclosure 19 Jun 2023, 5:23PM Advanced Enzyme Technologies informs about disclosure19 Jun 2023, 1:55PM Advanced Enzyme Technologies informs about disclosure16 Jun 2023, 4:03PM Advanced Enzyme Technologies informs about disclosure13 Jun 2023, 4:59PM Advanced Enzyme Technologies informs about disclosure 12 Jun 2023, 5:04PM Advanced Enzyme Technologies informs about analyst meet 7 Jun 2023, 2:45PM Advanced Enzyme Technologies informs about analyst meet 2 Jun 2023, 5:10PM Advanced Enzyme - Quaterly Results13 May 2023, 1:29PM Advanced Enzyme - Quaterly Results13 May 2023, 1:29PM Advanced Enzyme - Quaterly Results13 May 2023, 1:29PM Advanced Enzyme Technologies informs about analyst meet 20 Feb 2023, 5:08PM Advanced Enzyme Technologies informs about transcript of conference call18 Feb 2023, 10:58AM Advanced Enzyme Technologies informs about allotment of ESOP/ESPS11 Feb 2023, 12:32PM Advanced Enzyme - Quaterly Results11 Feb 2023, 12:18PM Advanced Enzyme - Quaterly Results11 Feb 2023, 12:18PM Advanced Enzyme - Quaterly Results11 Feb 2023, 12:18PM Advanced Enzyme Technologies acquires additional stake in JC Biotech4 Jan 2023, 10:21AM Advanced Enzyme Technologies acquires 50% stake in Saiganesh Enzytech Solutions4 Jan 2023, 9:59AM Advanced Enzyme Technologies informs about analyst meet 15 Dec 2022, 10:31AM

Advanced Enzyme Stock Price Analysis and Quick Research Report. Is Advanced Enzyme an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Advanced Enzyme and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Advanced Enzyme cash from the operating activity was Rs 50.296 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Advanced Enzyme has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Advanced Enzyme , the EPS growth was 1.83969810082449 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Advanced Enzyme has OPM of 24.1014480192855 % which is a good sign for profitability.
     
  • ROE: Advanced Enzyme have a average ROE of 11.0496544930824 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Advanced Enzyme is Rs 359.15. One can use valuation calculators of ticker to know if Advanced Enzyme share price is undervalued or overvalued.
Last Updated on:
Brief about Advanced Enzyme

Advanced Enzyme Technologies Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Advanced Enzyme Technologies Ltd. is a global player in the enzyme industry, specializing in research, development, manufacturing, and marketing of enzymes and probiotics. The company caters to a wide range of industries including human health, animal nutrition, baking, brewing, food processing, textile, and more. With a strong focus on innovation and sustainability, Advanced Enzyme Technologies has established itself as a trusted name in the enzyme market.

Advanced Enzyme Technologies Ltd. - Share Price

Stay up-to-date with the latest share price of Advanced Enzyme Technologies Ltd. Our website provides a real-time stock price tracking feature that allows investors to monitor the movement of the company's shares and make informed decisions. Whether you are a seasoned investor or just starting out, our user-friendly platform provides all the tools you need to stay informed about Advanced Enzyme Technologies' share price.

Advanced Enzyme Technologies Ltd. - Balance Sheet

Access the balance sheet of Advanced Enzyme Technologies Ltd. on our website. Our pre-built screening tools enable investors to analyze the financial health of the company. You can evaluate key performance indicators, such as revenue growth, profitability, and debt levels, to get a comprehensive overview of Advanced Enzyme Technologies' financial position.

Advanced Enzyme Technologies Ltd. - Annual Report

The annual report of Advanced Enzyme Technologies Ltd. is available for download on our website. This detailed report provides a comprehensive analysis of the company's performance over the past year. Investors can gain valuable insights into the company's strategies, financial results, market outlook, and future prospects. Our platform offers a user-friendly interface to access and navigate through the annual report easily.

Advanced Enzyme Technologies Ltd. - Dividend

Stay informed about the dividend history and payout policy of Advanced Enzyme Technologies Ltd. Our website provides a dedicated section where you can find the company's dividend record. Whether you are interested in regular income from dividend payouts or assessing the company's dividend stability, our platform provides the necessary information to make informed investment decisions.

Advanced Enzyme Technologies Ltd. - Quarterly Result

Analyze the quarterly financial performance of Advanced Enzyme Technologies Ltd. on our website. Our premium features allow investors to calculate fair value using analysis tools like the discounted cash flow (DCF) analysis, book value per share (BVPS) analysis, earnings multiple approach, and DuPont analysis. Stay up-to-date with the company's earnings, revenue growth, and key financial ratios to make informed investment decisions.

Advanced Enzyme Technologies Ltd. - Stock Price

Monitor the historical stock price movement of Advanced Enzyme Technologies Ltd. on our website. Our platform offers interactive price charts that provide a visual representation of the company's stock performance over time. Whether you are interested in assessing short-term trends or long-term patterns, our stock price charts will help you analyze the historical performance of Advanced Enzyme Technologies' stock.

Advanced Enzyme Technologies Ltd. - Price Chart

Our website features a comprehensive price chart of Advanced Enzyme Technologies Ltd. stock. This interactive chart allows investors to analyze the historical price movements, identify trends, and spot potential investment opportunities. Whether you are a technical analyst or a long-term investor, our price chart provides valuable insights into the stock's performance.

Advanced Enzyme Technologies Ltd. - News

Stay updated with the latest news and developments about Advanced Enzyme Technologies Ltd. Our website provides a reliable source of news articles related to the company. Investors can stay informed about industry trends, regulatory changes, product launches, partnerships, and other significant events that can impact Advanced Enzyme Technologies' business. Our news section keeps investors abreast of the latest updates, ensuring they have access to the information necessary to make informed investment decisions.

Advanced Enzyme Technologies Ltd. - Concall Transcripts

Access the conference call transcripts of Advanced Enzyme Technologies Ltd. on our website. Our platform provides downloadable transcripts of the company's earnings calls and other important conference calls. These transcripts offer investors an opportunity to gain insights into the company's management discussions, key announcements, and future plans. Reviewing the concall transcripts can provide valuable information for long-term stock investors.

Advanced Enzyme Technologies Ltd. - Investor Presentations

Download and review the investor presentations of Advanced Enzyme Technologies Ltd. on our website. These presentations offer a detailed overview of the company's business, financial performance, growth strategies, and key milestones. Investors can examine the company's market position, competitive advantage, and growth potential through these presentations. Stay informed and gain a deeper understanding of Advanced Enzyme Technologies' investment prospects through these investor presentations.

Advanced Enzyme Technologies Ltd. - Promoters

Learn about the promoters of Advanced Enzyme Technologies Ltd. Our website provides information about the key individuals driving the company's growth and success. Promoters play a crucial role in shaping the company's future and their expertise and vision contribute significantly to its performance. Understanding the background and qualifications of the promoters can assist investors in evaluating the leadership of Advanced Enzyme Technologies.

Advanced Enzyme Technologies Ltd. - Shareholders

Discover the major shareholders of Advanced Enzyme Technologies Ltd. Our website provides insights into the company's ownership structure, including institutional investors and individual shareholders. Understanding the composition of the shareholder base can offer valuable information about the market sentiment and confidence in the company's prospects. Monitor changes in the shareholder structure to stay informed about investor sentiment towards Advanced Enzyme Technologies.

Remember, you can access the annual reports, concall transcripts, investor presentations, credit ratings, and research reports of Advanced Enzyme Technologies Ltd. on our website. Our platform also offers premium features such as fair value calculations using tools like DCF analysis, BVPS analysis, earnings multiple approach, and DuPont analysis. Invest with confidence using the comprehensive analysis and information available on our website.

Read More
X